8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001193125-20-105266
Bylaws or fiscal year change · Other events
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d891585d8k.htm…